Published by Iain Gilbert on 12th March 2020
(Sharecast News) - US pharmaceutical firm Inovio has received a $5m grant from the Bill & Melinda Gates Foundation in order to accelerate the testing and scale-up of CELLECTRA 3PSP, a proprietary smart device used for the intradermal delivery of its coronavirus DNA vaccine.
URL: http://www.digitallook.com/dl/news/story/30378722/...